AWARDDEFINITIVE CONTRACTSmall business
Definitive contract 75A50223C00004MAXIM BIOMEDICAL, INC
Overview
Award facts
- Net obligations
- $2.70M
- $2,700,000of $2.70M potential value
- Outlays (paid to date)
- $2.70M
- $2.70M paid of $2.70M obligated$2,700,000
- Period of performance
- Dec 7, 2022 to Feb 24, 2023
- Ended
- Modifications
- 0
- Latest action Dec 7, 2022
- Contract type
- Definitive contract
- PIID 75A50223C00004
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
THE PURPOSE OF THIS CONTRACT IS TO PROCURE OVER THE COUNTER (OTC) COVID-19 TESTS.
Dates and value
- Award date
- Signed on Dec 7, 2022
- Potential end of performance
- Feb 23, 2023
- Current value
- $2,700,000Base and exercised options
- Potential value (if all options are exercised)
- $2,700,000
Obligations by fiscal year of action
- FY2023: $2,700,000
Total across 1 fiscal year: $2,700,000
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Dec 7, 2022. View on USAspending · Recipient on SAM.gov
Recipient
LocationROCKVILLE, MD
UEIYV7LJS28ERK8
CAGE code4EJW3
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyMAXIM BIOMEDICAL, INC
Business types and certifications
Self-certified small disadvantaged businessFor-profit organizationCorporation (not tax-exempt)Manufacturer of goods
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Funded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded from
- Public health and social services emergency fundProgram activities075-0140Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Rockville, Montgomery County, Maryland 20850-2452
- Congressional district (place of performance)
- MD-08As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (product)
Competition
- Extent competed
- Not competedC
- Reason not competed
- Urgency (FAR 6.302-2)URG
- Solicitation procedures
- Only one sourceSSS
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Contract details
- Subcontracting plan
- Plan not requiredB
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Dec 7, 2022Base obligation at award: $2,700,000
- Latest action
- Dec 7, 2022 — Base awardModification 0; obligation change +$2,700,000
- Actions by type
- Base award1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $2,700,000
- Latest action: change in base and all options
- $2,700,000
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Contingency, humanitarian or peacekeeping operation
- Presidential issued emergency declaration, or a major disaster declarationC
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Mfg in U.S.D
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7505
- Contracting office code
- 75A502
- Transactions recorded under this award key
- 1
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7505
- Funding office code
- 75A501
- Treasury accounts
- 075-X-0140-000
- Object classes
- 26.0: Supplies and materials
- Disaster or emergency funding (DEFC)
- P: Emergency P.L. 116-139
- COVID-19 supplemental obligations
- $2,700,000
- COVID-19 supplemental outlays
- $2,700,000